J. Dow Fitness Announces Spring Collection 2022

Blazing on the heels of the amazing nationwide feature at Target in February, J. Dow Fitness…

Gold’s Gym Celebrates Legacy of Joe Gold on his 100th Birthday

 In commemoration of what would’ve been Joe Gold’s 100th birthday, Gold’s Gym brought together icons of the past and…

Global Generic Injectables Market Research Report 2022: Expiration of Branded Drug Patents & Rising Approvals for Generic Injectable Drugs

The “Global Generic Injectables Market (2022 Edition) – Analysis By Molecule Type, (Small, Large), Therapeutic Area, Container…

Jefferson Health Makes Strides in Treating Loss of Smell and Taste

– A minimally invasive treatment for individuals suffering from loss of smell and taste could become…

Verana Health Launches Qdata™ Glaucoma to Deliver Real-World Insights into Glaucoma Patient Journey

 Verana Health, a digital health company that delivers quality drug lifecycle and medical practice insights from…

Professional Physical Therapy Celebrates National Athletic Training Month in March

 Professional Physical Therapy is a leading provider of outpatient physical therapy and rehabilitation services throughout New York, New…

Immuno-oncology Cell Therapy Market worth $34.69 Billion by 2030 – Exclusive Report by InsightAce Analytic

 InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on “Global Immuno-Oncology Cell Therapy…

Main Line Health’s Lankenau Medical Center in top 1% of U.S. hospitals and Riddle Hospital in top 2% in Healthgrades rankings

Lankenau Medical Center and Riddle Hospital, part of Main Line Health, today were recognized by Healthgrades as among the top hospitals…

VERSANT HEALTH AWARDED NCQA ACCREDITATION FOR UTILIZATION MANAGEMENT

Today, Versant Health, a leading managed vision care company, announced that it has received Utilization Management Accreditation…

EyePoint Pharmaceuticals Announces Updated Positive Interim Safety and Efficacy Data from Ongoing Phase 1 DAVIO Clinical Trial Evaluating EYP-1901 for the Treatment of Wet AMD

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to improve the…